Clinical Trial Update: Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety and efficacy of the Sonocloud device combined with nivolumab for brain metastases from melanoma, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Sonocloud device
• nivolumab (nivolumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Melanoma, Metastatic Melanoma | Phase 1, Phase 2 | Status: UNKNOWN